Sort
10,766 grants matching “checkpoint inhibitor”
A Regulatory Checkpoint in the Pathogenesis of Inflammatory Arthritis
$47,992Christian Stehlik · Northwestern University At Chicago · R01 · FY2015 · AR
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunity
$47,980Matthew Zachary Madden · Vanderbilt University · F30 · FY2021 · CA
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
$47,912Steven Duc Tran · Northwestern University At Chicago · F31 · FY2024 · LM
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$47,881George J Weiner · University Of Iowa · P50 · FY2019 · CA
Mechanisms of Immune Dysfunction and Morbid Outcome in Response to Shock/Sepsis
$47,875Alfred Ayala · Rhode Island Hospital · R35 · FY2017 · GM
Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
$47,694Bianca Diaz · Weill Medical Coll Of Cornell Univ · F31 · FY2023 · CA
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
$47,594Anil Shanker · Meharry Medical College · U54 · FY2021 · CA
Immuno-Oncology
$47,591Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2025 · CA
Immuno-Oncology
$47,589Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2024 · CA
Immuno-Oncology
$47,588Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2023 · CA
Metabolic reprogramming and tumor progression in LKB1 deficient NSCLC
$47,536Austin C Boese · Emory University · F99 · FY2021 · CA
The roles of UV, neoantigens, and epitope spreading in vitiligo and melanoma
$47,468Jennifer A Lo · Harvard Medical School · F30 · FY2016 · ES
Decoding tobacco-related oral cancer ecosystem by integrative approach
$47,336Aik Choon Tan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · DE
Characterizing the DPP8/9 Pyroptotic Checkpoint with Chemoproteomic Protease Substrate Profiling
$47,269Andrew Griswold · Weill Medical Coll Of Cornell Univ · F30 · FY2020 · CA
Regulating the ATR checkpoint through protein ubiquitylation
$47,210Richard C. Centore · Massachusetts General Hospital · F32 · FY2009 · GM
Immunology Research Program
$47,171Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Function of PD-1 Signaling on the Activity of B cells in the Tumor Microenvironment in Breast Cancer
$47,153Xiaolu Pan · Univ Of North Carolina Chapel Hill · F31 · FY2024 · CA
Pilot Project 2: Comprehensive characterization of tumor-immune interaction in cancer patients with African ancestry
$47,100Sanna M. Goyert · City College Of New York · U54 · FY2024 · CA
Pilot Project 2: Comprehensive Characterization of Immune Features Linked to Genetic Variants and Response to Immunotherapy
$47,100Sanna M. Goyert · City College Of New York · U54 · FY2025 · CA
Pglyrp3 cooperates with Snail1 to mediate anti-tumor immune response in breast cancer
$47,077Mathew Sebastian · University Of Florida · F30 · FY2021 · CA
The roles of UV, neoantigens, and epitope spreading in vitiligo and melanoma
$47,012Jennifer A Lo · Harvard Medical School · F30 · FY2015 · ES
Program 12: Developmental Therapeutics
$46,974Geoffrey I Shapiro · Dana-Farber Cancer Inst · P30 · FY2025 · CA
The roles of AP-1 pathway activation in NK cell development and exhaustion programming in AML
$46,851Erin G. Jeremy · Ohio State University · F30 · FY2025 · CA
Membrane Ubiquitin Ligase-Driven Immune Evasion in HPV+ Head and Neck Cancer
$46,848Lexi Vu · Henry Ford Health + Michigan State University Health Sciences · F31 · FY2024 · DE
FoxM1 and Oncogenic Pathways in Hepatocellular Carcinoma
$46,800Janai R. Carr-Ascher · University Of Illinois At Chicago · F31 · FY2011 · CA